Trials / Unknown
UnknownNCT02123355
The Effect of Dexmedetomidine to Cognition of Geriatrics in Prolonged Surgery
The Effect of Dexmedetomidine to Cognition of Geriatrics in Prolonged Surgery,A Randomized Controlled Study
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Shaanxi Provincial People's Hospital · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
The incidence of postoperative cognitive dysfunction (POCD) is high and POCD affect the life quality and the prognosis of patients. Geriatrics is the independent risk factor of POCD, and POCD is also correlated with many other factors such as type of surgery, the duration of anesthesia and the anesthesia drugs used et al. So, the prevention and treatment of POCD in geriatrics is important. Dexmedetomidine is found to have the effect of neuro-protection, but it is controversy whether Dexmedetomidine has the effect of neuro-protection in geriatrics, especially the prolonged surgery. The purpose of this study is to explore the effect of Dexmedetomidine to the cognitive function at prolonged surgery in geriatrics in geriatrics.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Induction of anesthesia | Midazolam 0.05 mg/kg、Propofol 1.0 mg/kg、Sufentanyl 3μg/kg、Victracurium 0.1 mg/kg sequential intravenous injection |
| PROCEDURE | Intubation | After muscle relaxed and loss of eyelash reflex of the patients, intubation is done,then mechanical ventilation is performed, and maintain the PETCO2于35\~40 mmHg,pulse oxygen saturation is more than 95%. |
| DRUG | Sevoflurane, remifentanil ,vecuronium | Sevoflurane(1%-2%)is inspirated, and remifentanil 0.1-0.5μg/kg//min is continuously pumped,vecuronium 0.03 mg/kg is injected intermittently. |
| DRUG | Dexmedetomidine | Dexmedetomidine is given at 0.5μg/kg/h by continuous infusion and is stopped to given 30 minutes before the surgery is over. |
| DRUG | Placebo | Normal saline is given at 0.5μg/kg/h by continuous infusion and is stopped to given 30 minutes before the surgery is over. |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2014-08-01
- Completion
- 2014-08-01
- First posted
- 2014-04-25
- Last updated
- 2014-04-25
Source: ClinicalTrials.gov record NCT02123355. Inclusion in this directory is not an endorsement.